143 related articles for article (PubMed ID: 12473944)
21. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S
Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of angiogenesis in non-small cell lung cancer.
Giatromanolaki A
Anticancer Res; 2001; 21(6B):4373-82. PubMed ID: 11908693
[TBL] [Abstract][Full Text] [Related]
23. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
24. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M
Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of elevation of vascular endothelial growth factor family expression in patients with non-small cell lung cancer: an updated meta-analysis.
Zheng CL; Qiu C; Shen MX; Qu X; Zhang TH; Zhang JH; Du JJ
Asian Pac J Cancer Prev; 2015; 16(5):1881-95. PubMed ID: 25773840
[TBL] [Abstract][Full Text] [Related]
26. Inverse prognostic impact of angiogenic marker expression in tumor cells versus stromal cells in non small cell lung cancer.
Donnem T; Al-Saad S; Al-Shibli K; Delghandi MP; Persson M; Nilsen MN; Busund LT; Bremnes RM
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6649-57. PubMed ID: 18006765
[TBL] [Abstract][Full Text] [Related]
27. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
28. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.
Tsao MS; Liu N; Nicklee T; Shepherd F; Viallet J
Clin Cancer Res; 1997 Oct; 3(10):1807-14. PubMed ID: 9815567
[TBL] [Abstract][Full Text] [Related]
29. Expression of vascular endothelial growth factor (VEGF) and its receptor FLK-1 in non-small cell lung cancer (NSCLC)--a preliminary report.
Dziadziuszko R; Chyczewski L; Jassem E; Jassem J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():100-1. PubMed ID: 11820558
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer.
Liao M; Wang H; Lin Z; Feng J; Zhu D
Lung Cancer; 2001; 33(2-3):125-32. PubMed ID: 11551407
[TBL] [Abstract][Full Text] [Related]
32. Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in small-cell and non-small-cell lung carcinomas.
Stefanou D; Batistatou A; Arkoumani E; Ntzani E; Agnantis NJ
Histol Histopathol; 2004 Jan; 19(1):37-42. PubMed ID: 14702169
[TBL] [Abstract][Full Text] [Related]
33. [Vascular endothelial growth factor--fundamental research and experimental study in plastic surgery].
Huang CY; Shen ZY
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan; 16(1):64-9. PubMed ID: 11826659
[TBL] [Abstract][Full Text] [Related]
34. [Expression of vascular endothelial growth factor and its receptors in endometrial carcinoma].
Wang H; Chen G; Zhang B
Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):391-5. PubMed ID: 12485477
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor expression in non-small cell lung cancer.
O'Byrne KJ; Goddard J; Giatromanolaki A; Koukourakis MI
Methods Mol Med; 2003; 74():357-73. PubMed ID: 12415708
[No Abstract] [Full Text] [Related]
36. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer.
Yano T; Tanikawa S; Fujie T; Masutani M; Horie T
Eur J Cancer; 2000 Mar; 36(5):601-9. PubMed ID: 10738124
[TBL] [Abstract][Full Text] [Related]
37. Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis.
Niklińska W; Burzykowski T; Chyczewski L; Nikliński J
Lung Cancer; 2001 Dec; 34 Suppl 2():S59-64. PubMed ID: 11720743
[TBL] [Abstract][Full Text] [Related]
38. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
[TBL] [Abstract][Full Text] [Related]
39. The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer.
Kang YH; Kim KS; Yu YK; Lim SC; Kim YC; Park KO
J Korean Med Sci; 2001 Aug; 16(4):417-23. PubMed ID: 11511786
[TBL] [Abstract][Full Text] [Related]
40. Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.
Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Cox G; Thorpe PE; Gatter KC; Harris AL
Clin Cancer Res; 2000 May; 6(5):1917-21. PubMed ID: 10815916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
